Immunohistochemical Expression and Prognostic Value of ER, PR and HER2/neu in Pancreatic and Small Intestinal Neuroendocrine Tumors
Thomas Arnason(Dalhousie University), Daniel Rayson, Mohamed Abdolell(Dalhousie University), Magdalena Drewniak(Dalhousie University), Penelope J. Barnes(Dalhousie University), Heidi Sapp(Queen Elizabeth II Health Sciences Centre)
Cited by 38
Related Papers
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes
|JAMA Oncology|2016|375
Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
|Canadian Journal of Cardiology|2016|234
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
|Thrombosis Research|2005|194
Pegylated liposomal doxorubicin-associated hand–foot syndrome: Recommendations of an international panel of experts
|European Journal of Cancer|2008|128